EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into RNA ‐mediated pathology in new mouse models of Huntington's disease

Magdalena Wozna-Wysocka iD, Magdalena Jazurek-Ciesiolka iD, Lukasz Przybyl iD, Dorota Wronka iD, Julia Oliwia Misiorek iD, Joanna Suszynska-Zajczyk iD, Grzegorz Figura iD, Adam Ciesiolka iD, Paula Sobieszczanska, Anna Zeller iD, Magdalena Niemira iD, Pawel Michal Switonski iD und 1 weitere

The FASEB Journal · 15.12.2024 · 38 (23)

DOI: 10.1096/fj.202401465r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 27.11.2024. Verfasst von Magdalena Wozna-Wysocka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland. Hauptthemen laut MEDLINE: Huntington Disease, Disease Models, Animal, Huntingtin Protein. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington's disease (HD) is a neurodegenerative polyglutamine (polyQ) disease resulting from the expansion of CAG repeats located in the ORF of the huntingtin gene ( HTT ). The extent to which mutant mRNA‐driven disruptions contribute to HD pathogenesis, particularly in comparison to the dominant mechanisms related to the gain‐of‐function effects of the mutant polyQ protein, is still debatable. To evaluate this contribution in vivo, we generated two mouse models through a knock‐in strategy at the Rosa26 locus. These models expressed distinct variants of human mutant HTT cDNA fragment: a translated variant (HD/100Q model, serving as a reference) and a nontranslated variant (HD/100CAG model). The cohorts of animals were subjected to a broad spectrum of molecular, behavioral, and cognitive analysis for 21 months. Behavioral testing revealed alterations in both models, with the HD/100Q model exhibiting late disease phenotype. The rotarod, static rod, and open‐field tests showed some motor deficits in HD/100CAG and HD/100Q model mice during the light phase, while ActiMot indicated hyperkinesis during the dark phase. Both models also exhibited certain gene deregulations in the striatum that are related to disrupted pathways and phenotype alterations observed in HD. In conclusion, we provide in vivo evidence for a minor contributory role of mutant RNA in HD pathogenesis. The separated effects resulting from the presence of mutant RNA in the HD/100CAG model led to less severe but, to some extent, similar types of impairments as in the HD/100Q model. Increased anxiety was one of the most substantial effects caused by mutant HTT RNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseDisease Models, AnimalHuntingtin ProteinAnimalsMiceHumansMice, TransgenicMaleMice, Inbred C57BLBehavior, AnimalGene Knock-In TechniquesRNAMotor ActivityRNA, Messenger

Stichwörter der Autor:innen

Huntington's diseaseRNA toxicitymouse modelneurodegenerative diseasespolyglutamine disorders

Substanzen

Huntingtin ProteinHTT protein, humanRNARNA, Messenger

Autor:innen und Institutionen

  • Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
  • Department of Biochemistry and Biotechnology, Poznan University of Life Sciences, Poznan, Poland.
  • Genomics and Epigenomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.

ORCID-Profile: Magdalena Wozna-Wysocka, Magdalena Jazurek-Ciesiolka, Lukasz Przybyl, Dorota Wronka, Julia Oliwia Misiorek, Joanna Suszynska-Zajczyk, Grzegorz Figura, Adam Ciesiolka, Anna Zeller, Magdalena Niemira, Pawel Michal Switonski, Agnieszka Fiszer

Förderung

  • National Science Centre
  • Narodowe Centrum Nauki

Zitieren

APA

Wozna-Wysocka, M., Jazurek-Ciesiolka, M., Przybyl, L., Wronka, D., Misiorek, J. O., Suszynska-Zajczyk, J., Figura, G., Ciesiolka, A., Sobieszczanska, P., Zeller, A., Niemira, M., Switonski, P. M., & Fiszer, A. (2024). Insights into RNA ‐mediated pathology in new mouse models of Huntington's disease. The FASEB Journal, 38(23). https://doi.org/10.1096/fj.202401465r

Vancouver

Wozna-Wysocka M, Jazurek-Ciesiolka M, Przybyl L, Wronka D, Misiorek JO, Suszynska-Zajczyk J, et al. Insights into RNA ‐mediated pathology in new mouse models of Huntington's disease. The FASEB Journal. 2024;38(23). doi:10.1096/fj.202401465r

BibTeX
@article{WoznaWysocka2024,
  author = {Wozna-Wysocka, Magdalena and Jazurek-Ciesiolka, Magdalena and Przybyl, Lukasz and Wronka, Dorota and Misiorek, Julia Oliwia and Suszynska-Zajczyk, Joanna and Figura, Grzegorz and Ciesiolka, Adam and Sobieszczanska, Paula and Zeller, Anna and Niemira, Magdalena and Switonski, Pawel Michal and Fiszer, Agnieszka},
  title = {Insights into RNA ‐mediated pathology in new mouse models of Huntington's disease},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {23},
  doi = {10.1096/fj.202401465r}
}
Kostenlos starten →